Applicant, as named in the Orange Book

Lantheus

Next listed expiry: Neuraceq on 14 Jul 2032. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Neuraceq florbetaben f-18	florbetaben f-18	204677	14 Jul 2032	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.